Sox, you're misunderstanding Alan's posts. I have pointed
Sox, you're misunderstanding Alan's posts. I have pointed this out many times before. Alan never has stated that he believes that every single share marked as a short sale REMAINS short at the close -- never.
We ALL know that some of those short sales are daytrader activities and are closed out by the end of the day. Some of them are market makers taking advantage of their ability to see the Level 3 books, so that they short some stock to someone who has a high bid in, and then they buy stock to cover that short from a lower level. This is one of the problems with OTC stocks -- the 4 electronic exchanges that are independent and make it easier for the market makers to do this.
And finally, some of those short shares are held short. Otherwise we wouldn't have the 1.2 million shares listed as legal short sales -- by FINRA.
So please stop saying that Alan is claiming that all those shares are held short and that the percentage indicates cumulative short positions. He's never said that.
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...
Continue Reading
They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...
Continue Reading
Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...
Continue Reading
Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...
Continue Reading
Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...
Continue Reading
AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...
Continue Reading
Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...
Continue Reading
Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...
Continue Reading
A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...
Continue Reading
A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...
Continue Reading
Top 5 Most Recently Viewed Articles
Revolutionizing Plumbing with the Urinal Offset Flange Plumbing issues often arise when installations do not align as planned. A new solution has emerged from an inventor who recognized this challenge while working as a plumbing contractor. By inventing the Urinal Offset Flange, the goal was to create a functional product that would help offset any urinal sewer stub-out,...
Continue Reading
Evolent Health got a solid boost when Truist Securities reaffirmed their Buy rating, slapping a price target of $33 on it. This came after the Centers for Medicare & Medicaid Services (CMS) laid down some hefty projections about Medicare Advantage enrollment hitting around 35.7 million lives. You know what that means for the health insurers, right? They’ve gotta step up...
Continue Reading
Analyzing Eversource Energy's Stock Performance In the latest market developments, Eversource Energy Inc. (NYSE: ES) sees its share price settle at $64.56, following a modest increase of 0.26%. Despite facing a downturn of 2.02% over the past month, the stock has managed to rise 11.14% over the previous year. Investors may be pondering whether this pricing suggests...
Continue Reading
Heron Therapeutics Appoints Thomas Cusack to its Board Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company, has announced that Thomas Cusack is now part of its Board of Directors. This strategic decision is expected to enhance the company’s governance and provide valuable insights derived from Mr. Cusack's extensive experience in corporate...
Continue Reading
Innovative Health Tool for Emergency Situations In an ever-evolving healthcare landscape, the introduction of new health tools has become essential for improving patient outcomes. An inventive product known as PALPATE has recently emerged, offering a unique solution that addresses the critical need for maintaining consciousness in emergency situations. The creator of this...
Continue Reading